Cargando…

Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design

[Image: see text] The absorption of poorly water-soluble drugs is influenced by the luminal gastrointestinal fluid content and composition, which control solubility. Simulated intestinal fluids have been introduced into dissolution testing including endogenous amphiphiles and digested lipids at phys...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhou, Dunn, Claire, Khadra, Ibrahim, Wilson, Clive G., Halbert, Gavin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717620/
https://www.ncbi.nlm.nih.gov/pubmed/28749696
http://dx.doi.org/10.1021/acs.molpharmaceut.7b00354
_version_ 1783284176585228288
author Zhou, Zhou
Dunn, Claire
Khadra, Ibrahim
Wilson, Clive G.
Halbert, Gavin W.
author_facet Zhou, Zhou
Dunn, Claire
Khadra, Ibrahim
Wilson, Clive G.
Halbert, Gavin W.
author_sort Zhou, Zhou
collection PubMed
description [Image: see text] The absorption of poorly water-soluble drugs is influenced by the luminal gastrointestinal fluid content and composition, which control solubility. Simulated intestinal fluids have been introduced into dissolution testing including endogenous amphiphiles and digested lipids at physiological levels; however, in vivo individual variation exists in the concentrations of these components, which will alter drug absorption through an effect on solubility. The use of a factorial design of experiment and varying media by introducing different levels of bile, lecithin, and digested lipids has been previously reported, but here we investigate the solubility variation of poorly soluble drugs through more complex biorelevant amphiphile interactions. A four-component mixture design was conducted to understand the solubilization capacity and interactions of bile salt, lecithin, oleate, and monoglyceride with a constant total concentration (11.7 mM) but varying molar ratios. The equilibrium solubility of seven low solubility acidic (zafirlukast), basic (aprepitant, carvedilol), and neutral (fenofibrate, felodipine, griseofulvin, and spironolactone) drugs was investigated. Solubility results are comparable with literature values and also our own previously published design of experiment studies. Results indicate that solubilization is not a sum accumulation of individual amphiphile concentrations, but a drug specific effect through interactions of mixed amphiphile compositions with the drug. This is probably due to a combined interaction of drug characteristics; for example, lipophilicity, molecular shape, and ionization with amphiphile components, which can generate specific drug–micelle affinities. The proportion of each component can have a remarkable influence on solubility with, in some cases, the highest and lowest points close to each other. A single-point solubility measurement in a fixed composition simulated media or human intestinal fluid sample will therefore provide a value without knowledge of the surrounding solubility topography meaning that variability may be overlooked. This study has demonstrated how the amphiphile ratios influence drug solubility and highlights the importance of the envelope of physiological variation when simulating in vivo drug behavior.
format Online
Article
Text
id pubmed-5717620
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-57176202017-12-07 Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design Zhou, Zhou Dunn, Claire Khadra, Ibrahim Wilson, Clive G. Halbert, Gavin W. Mol Pharm [Image: see text] The absorption of poorly water-soluble drugs is influenced by the luminal gastrointestinal fluid content and composition, which control solubility. Simulated intestinal fluids have been introduced into dissolution testing including endogenous amphiphiles and digested lipids at physiological levels; however, in vivo individual variation exists in the concentrations of these components, which will alter drug absorption through an effect on solubility. The use of a factorial design of experiment and varying media by introducing different levels of bile, lecithin, and digested lipids has been previously reported, but here we investigate the solubility variation of poorly soluble drugs through more complex biorelevant amphiphile interactions. A four-component mixture design was conducted to understand the solubilization capacity and interactions of bile salt, lecithin, oleate, and monoglyceride with a constant total concentration (11.7 mM) but varying molar ratios. The equilibrium solubility of seven low solubility acidic (zafirlukast), basic (aprepitant, carvedilol), and neutral (fenofibrate, felodipine, griseofulvin, and spironolactone) drugs was investigated. Solubility results are comparable with literature values and also our own previously published design of experiment studies. Results indicate that solubilization is not a sum accumulation of individual amphiphile concentrations, but a drug specific effect through interactions of mixed amphiphile compositions with the drug. This is probably due to a combined interaction of drug characteristics; for example, lipophilicity, molecular shape, and ionization with amphiphile components, which can generate specific drug–micelle affinities. The proportion of each component can have a remarkable influence on solubility with, in some cases, the highest and lowest points close to each other. A single-point solubility measurement in a fixed composition simulated media or human intestinal fluid sample will therefore provide a value without knowledge of the surrounding solubility topography meaning that variability may be overlooked. This study has demonstrated how the amphiphile ratios influence drug solubility and highlights the importance of the envelope of physiological variation when simulating in vivo drug behavior. American Chemical Society 2017-07-27 2017-12-04 /pmc/articles/PMC5717620/ /pubmed/28749696 http://dx.doi.org/10.1021/acs.molpharmaceut.7b00354 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Zhou, Zhou
Dunn, Claire
Khadra, Ibrahim
Wilson, Clive G.
Halbert, Gavin W.
Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
title Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
title_full Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
title_fullStr Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
title_full_unstemmed Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
title_short Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
title_sort influence of physiological gastrointestinal surfactant ratio on the equilibrium solubility of bcs class ii drugs investigated using a four component mixture design
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717620/
https://www.ncbi.nlm.nih.gov/pubmed/28749696
http://dx.doi.org/10.1021/acs.molpharmaceut.7b00354
work_keys_str_mv AT zhouzhou influenceofphysiologicalgastrointestinalsurfactantratioontheequilibriumsolubilityofbcsclassiidrugsinvestigatedusingafourcomponentmixturedesign
AT dunnclaire influenceofphysiologicalgastrointestinalsurfactantratioontheequilibriumsolubilityofbcsclassiidrugsinvestigatedusingafourcomponentmixturedesign
AT khadraibrahim influenceofphysiologicalgastrointestinalsurfactantratioontheequilibriumsolubilityofbcsclassiidrugsinvestigatedusingafourcomponentmixturedesign
AT wilsoncliveg influenceofphysiologicalgastrointestinalsurfactantratioontheequilibriumsolubilityofbcsclassiidrugsinvestigatedusingafourcomponentmixturedesign
AT halbertgavinw influenceofphysiologicalgastrointestinalsurfactantratioontheequilibriumsolubilityofbcsclassiidrugsinvestigatedusingafourcomponentmixturedesign